Nickson Catherine M, Moori Parisa, Carter Rachel J, Rubbi Carlos P, Parsons Jason L
Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L3 9TA, UK.
Oncotarget. 2017 May 2;8(18):29963-29975. doi: 10.18632/oncotarget.16265.
Patients with human papillomavirus type 16 (HPV)-associated oropharyngeal squamous cell carcinomas (OPSCC) display increased sensitivity to radiotherapy and improved survival rates in comparison to HPV-negative forms of the disease. However the cellular mechanisms responsible for this characteristic difference are unclear. Here, we have investigated the contribution of DNA damage repair pathways to the in vitro radiosensitivity of OPSCC cell lines. We demonstrate that two HPV-positive OPSCC cells are indeed more radiosensitive than two HPV-negative OPSCC cells, which correlates with reduced efficiency for the repair of ionising radiation (IR)-induced DNA double strand breaks (DSB). Interestingly, we show that HPV-positive OPSCC cells consequently have upregulated levels of the proteins XRCC1, DNA polymerase β, PNKP and PARP-1 which are involved in base excision repair (BER) and single strand break (SSB) repair. This translates to an increased capacity and efficiency for the repair of DNA base damage and SSBs in these cells. In addition, we demonstrate that HPV-positive but interestingly more so HPV-negative OPSCC display increased radiosensitivity in combination with the PARP inhibitor olaparib. This suggests that PARP inhibition in combination with radiotherapy may be an effective treatment for both forms of OPSCC, particularly for HPV-negative OPSCC which is relatively radioresistant.
与16型人乳头瘤病毒(HPV)相关的口咽鳞状细胞癌(OPSCC)患者相较于HPV阴性的该疾病患者,对放疗表现出更高的敏感性,生存率也更高。然而,造成这种特征差异的细胞机制尚不清楚。在此,我们研究了DNA损伤修复途径对口咽鳞状细胞癌细胞系体外放射敏感性的影响。我们证明,两种HPV阳性的口咽鳞状细胞癌细胞确实比两种HPV阴性的口咽鳞状细胞癌细胞对放疗更敏感,这与电离辐射(IR)诱导的DNA双链断裂(DSB)修复效率降低相关。有趣的是,我们发现HPV阳性的口咽鳞状细胞癌细胞中参与碱基切除修复(BER)和单链断裂(SSB)修复的蛋白质XRCC1、DNA聚合酶β、PNKP和PARP-1的水平上调。这意味着这些细胞修复DNA碱基损伤和单链断裂的能力和效率增强。此外,我们证明HPV阳性但有趣的是HPV阴性的口咽鳞状细胞癌与PARP抑制剂奥拉帕尼联合使用时放射敏感性增加。这表明PARP抑制与放疗联合可能是两种类型口咽鳞状细胞癌的有效治疗方法,特别是对于相对放射抵抗的HPV阴性口咽鳞状细胞癌。